Postagens

Mostrando postagens de janeiro, 2016

Best Use of Approved Therapies for Bone Metastases in Prostate cancer Matthew Raymond Smith , MD, PhD

http://meetinglibrary.asco.org/content/117060?media=vm
Postar um comentário
Leia mais

The role of adjuvant radiotherapy in pathologically node positive prostate cancer.

Imagem
Postar um comentário
Leia mais

Duration of androgen deprivation therapy for high-risk prostate cancer: Application of randomized trial data in a tertiary referral cancer center

Imagem
Postar um comentário
Leia mais

EORTC trial 22991: Results of a phase III study comparing 6 months of androgen suppression and irradiation versus irradiation alone for localized T1b-cT2aN0M0 prostate cancer. Abstract No: 22

Imagem
Postar um comentário
Leia mais

NRG Oncology RTOG 0415: A randomized phase III non-inferiority study comparing two fractionation schedules in patients with low-risk prostate cancer.

http://meetinglibrary.asco.org/content/119401?media=vm
Postar um comentário
Leia mais